Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

UTI Mutual Fund

UTI Medium to Long Duration Fund-Growth - Direct

★★★★★ 3rd-party

External rating

  • Source: Third-party data provider (Groww/CRISIL)
  • Original rating: 2/5, displayed as-is — TopFund does not modify third-party ratings
  • Refresh frequency: Whenever TopFund re-syncs this fund's data
  • Limitations: The provider's own rating methodology isn't disclosed here — see the provider's own site for their criteria

Full rating methodology →

TopFund Score: 43/100 · Weak

How this score is calculated

  • Star rating (35%)2/5
  • 3Y CAGR (30%)6.21%
  • Expense ratio (20%)1.32%
  • AUM (15%)₹303 Cr

Not investment advice — an analytical read of public fund data. Methodology →

UTI Mutual Fund · Income/Debt Oriented · Medium to Long Term Fund

₹83.41

-0.03 (-0.03%)

AUM: ₹303 Cr

NAV updated about 23 hours ago

Plan

Direct

Option

Growth

Risk

Moderate

Expense Ratio

1.32%

Exit Load

Nil

Fund Manager

Amandeep Chopra

Inception

Jan 2013

Benchmark

CRISIL Medium to Long Duration Debt A-III Index

Sharpe Ratio

-1.69

Std Dev (1Y)

2.05%

Historical Returns (CAGR)

Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.

1m

+0.61%

3m

-0.23%

6m

+2.76%

1y

+2.89%

3y

+6.21%

5y

+6.91%

10y

+5.03%

since inception

+6.64%

TopFund's Take on UTI Medium to Long Duration Fund-Growth - Direct

UTI Medium to Long Duration Fund-Growth - Direct lags behind most of its peers in the Medium to Long Term Fund category, currently carrying a 2-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 43/100.

Cost: At 1.32%, the expense ratio runs 140% above the Medium to Long Term Fund category average of 0.55%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -1.69 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, annualised volatility of 2.05% is on the lower side for a Medium to Long Term Fund fund, suggesting a comparatively smoother ride.

Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Income/Debt Oriented fund.

This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.

Sector Allocation

Financial 29.02%
Entities 15.18%
Technology 9.81%
Healthcare 8.19%
Materials 5.69%

Asset Allocation

Non Convertible Debenture 21.04%
State Development Loan 20.71%
Debenture 20.62%
GOI Securities 15.18%
Securitised Debt 10.44%
Bonds/NCDs 4.94%
Bonds/Debentures 3.30%
Net Current Assets 3.23%
Alternative Investment Fund 0.32%
CBLO 0.21%

Frequently Asked Questions about UTI Medium to Long Duration Fund-Growth - Direct

* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

No comments yet — start the discussion.